Dia Beta Labs - About the company
Dia Beta Labs is a seed company based in Belfast (United Kingdom), founded in 2022 by Nigel Irwin, Peter Simpson and Ryan Lafferty. It operates as a Developer of novel therapeutic peptides for metabolic disease treatment. Dia Beta Labs has raised $3.5M in funding from DSW Ventures. The company has 559 active competitors, including 204 funded and 106 that have exited. Its top competitors include companies like Rhythm Pharmaceuticals, MannKind Corp and Corcept.
Company Details
Developer of novel therapeutic peptides for metabolic disease treatment. The company focused on developing novel therapeutic agents for metabolic diseases, particularly targeting the progressive decline of pancreatic beta-cell health in diabetes and obesity. They emphasize peptide analogues that are enzyme resistant, receptor selective, and highly soluble for better formulation. It aims for treatments that offer more sustainable, quality weight loss and better management of disease progression compared to current options.
- Website
- diabetalabs.com
- Email ID
- *****@diabetalabs.com
- Registered Address
- 4 MURRAY HOUSE,MURRAY STREET,BELFAST,ANTRIM,UNITED KINGDOM,BT1 6DN
Key Metrics
Founded Year
2022
Location
Belfast, United Kingdom
Stage
Seed
Total Funding
$3.5M in 4 rounds
Latest Funding Round
Investors
Ranked
189th among 559 active competitors
Employee Count
6 as on Sep 30, 2026
Similar Companies
Legal entities associated with Dia Beta Labs
Dia Beta Labs is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
DIA BETA LABS LTD CIN: NI687456 , United Kingdom, Active | Apr 12, 2022 | - | 1 (As on Apr 30, 2024) |
Sign up to download Dia Beta Labs' company profile
Dia Beta Labs's funding and investors
Dia Beta Labs has raised a total funding of $3.5M over 4 rounds. Its first funding round was on Oct 04, 2024. Its latest funding round was a Seed round on Jun 25, 2025 for $*****. 1 investor participated in its latest round. Dia Beta Labs has 5 institutional investors.
Here is the list of recent funding rounds of Dia Beta Labs:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 25, 2025 | 9990985 | Seed | 3150683 | 9820842 | 8161647 | 8595314 |
Jan 13, 2025 | 5571214 | Seed | 4608365 | 2945216 | 4488896 | |
Jan 13, 2025 | 5033913 | Grant (prize money) | 7696540 | 1241111 | 4601458 |
Access funding benchmarks and valuations. Sign up today!View details of Dia Beta Labs's funding rounds and investors
Dia Beta Labs' founders and board of directors
Founder? Claim ProfileThe founders of Dia Beta Labs are Nigel Irwin, Peter Simpson and Ryan Lafferty. Ryan Lafferty is the CEO of Dia Beta Labs.
Here are the details of Dia Beta Labs' key team members:
- Nigel Irwin: Co-Founder of Dia Beta Labs. They serve on the board of 1 company.
- Peter Simpson: Co-Founder of Dia Beta Labs. They serve on the board of 1 company.
- Ryan Lafferty: Co-Founder & CEO of Dia Beta Labs. They serve on the board of 1 company.
Dia Beta Labs' Board of Directors
Dia Beta Labs's board has 4 active members. Nigel Irwin, Peter Simpson and Ryan Lafferty are part of team and Chacko Alexander is independent board member.Here is the list of Dia Beta Labs' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 3y 10m | |
Team | - | Current | 3y 10m | |
Team | - | Current | 4y 6m | |
Independent board member | - | Current | 3y 10m |
View details of Dia Beta Labs's Founder profiles and Board Members
Dia Beta Labs' employee count trend
Dia Beta Labs has 6 employees as of Sep 26. Here is Dia Beta Labs's employee count trend over the years:
Uncover Dia Beta Labs' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Dia Beta Labs's Competitors and alternates
Top competitors of Dia Beta Labs include Rhythm Pharmaceuticals, MannKind Corp and Corcept. Here is the list of Top 10 competitors of Dia Beta Labs, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Rhythm Pharmaceuticals 2010, Boston (United States), Public | Developer of peptide therapeutics for the treatment of rare genetic deficiencies | $84M | 72/100 | |
2nd | MannKind Corp 1991, Los Angeles (United States), Public | Developer of small-molecule drugs | $50M | 71/100 | |
3rd | Corcept 1998, Menlo Park (United States), Public | Developer of cortisol modulators for the treatment of various diseases | - | 69/100 | |
4th |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 69/100 | |
5th |  Structure 2017, San Francisco (United States), Public | Developer of oral small molecule drugs for chronic diseases | $191M | 67/100 | |
6th | Kailera 2024, Waltham (United States), Public | Developer of therapies for treating obesity and related conditions | $1B | 67/100 | |
7th | Assembly Biosciences 2005, New York City (United States), Public | Developing novel antivirals to treat serious viral diseases | $700K | 67/100 | |
8th | Rezolute 2012, Denver (United States), Public | Developing transformative therapies for rare diseases, focusing on hyperinsulinism (HI) | - | 66/100 | |
9th | Lexicon Pharmaceuticals 1995, The Woodlands (United States), Public | Developer of small molecule drugs for diffrent health diseases | - | 65/100 | |
10th |  Rani Therapeutics 2012, San Jose (United States), Public | Developer of technology for the oral delivery of large drug molecules | $226M | 65/100 | |
189th |  Dia Beta Labs 2022, Belfast (United Kingdom), Seed | Developer of novel therapeutic peptides for metabolic disease treatment | $3.5M | 37/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Dia Beta Labs's competitors? Click here to see the top ones
Dia Beta Labs's Investments and acquisitions
Dia Beta Labs has made no investments or acquisitions yet.
Reports related to Dia Beta Labs
Here is the latest report on Dia Beta Labs's sector:
News related to Dia Beta Labs
•
£3M Investment Boosts Coleraine Companies Targeting Cancer, Metabolic DiseasesManufacturing-Supply-Chain•Jun 26, 2025•StimOxyGen, Invest Northern Ireland, Dia Beta Labs, Clarendon Fund Managers
•
StimOxyGen and Dia Beta Labs secure first backing from Invest NI’s £39m Co-Fund IIIBELFAST NEWS LETTER LIMITED•Jun 25, 2025•StimOxyGen, Dia Beta Labs
•
Dia Beta Labs secures £1.2m to advance breakthrough obesity and type 2 diabetes drugsUKBAA•Jan 13, 2025•Dia Beta Labs, Gov, Qubis, DSW Ventures
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Dia Beta Labs
Explore our recently published companies
- Trove - Santa Monica based, Unfunded company
- Thunder Masonry - Unfunded company
- NXN Systems - South Korea based, 2022 founded, Unfunded company
- Primordial Ventures - Fort Myers based, 2021 founded, Unfunded company
- METASLAY - Brand - Visakhapatnam based, 2022 founded, Unfunded company
- Tibnology - India based, Unfunded company
